DSGNDesign Therapeutics, Inc.
$11.49+77% 1Y
$11.49
$5.5352 weeks$15.94
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Rangebound, no clear trend. Price is −5% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How DSGN is trading
Design Therapeutics, Inc. is +77% over the past year while the S&P 500 is +18%: 59 points ahead of the market.
+77%
1-year return · S&P 500 +18%
- vs 200-day average
- −4.8%
vs 200-day average · below trend, but not far
- RSI (14)
- 40
RSI (14) · neutral
- Below its 52-week high
- 28%
Below its 52-week high
Details›
- Last close2026-10-08
- $11.49
- 1 monthS&P 500 +1.6%
- −24%
- 1 yearS&P 500 +18%
- +77%
- 5 yearsS&P 500 +86%
- −22%
- vs 50-day average$13.79
- −17%
- 52-week high
- $15.94
- 52-week low
- $5.53
- Annualised volatility
- 82%
| Year | Return |
|---|---|
| 2026 (year to date) | +22% |
| 2025 | +52% |
| 2024 | +133% |
| 2023 | −74% |
| 2022 | −52% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 1 of 5 | −18% |
| Feb | 5 | 4 of 5 | +3.4% |
| Mar | 5 | 3 of 5 | +5.4% |
| Apr | 6 | 3 of 6 | +2.4% |
| May | 6 | 2 of 6 | −6.6% |
| Jun | 6 | 3 of 6 | +1.9% |
| Jul | 6 | 4 of 6 | +16% |
| Aug | 6 | 4 of 6 | −0.82% |
| Sep | 6 | 2 of 6 | +0.66% |
| Oct | 6 | 1 of 6 | −5.9% |
| Nov | 5 | 4 of 5 | +14% |
| Dec | 5 | 3 of 5 | +2.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.